EPE048 | Accelerating HIV epidemic control in Benue State, Nigeria, 2019-2021: the APIN program experience | E-poster | Implementation science of scaling up HIV treatment |
EPE049 | Evaluating the impact of WHO's Treat-All guideline on disease progression for people living with HIV in Central Africa from cohort data by target trial design and multi-state modeling | E-poster | Implementation science of scaling up HIV treatment |
EPE050 | Factors associated with healthcare providers' preference for forgoing an oral lead-in phase when initiating long-acting injectable cabotegravir and rilpivirine in the SOLAR clinical trial | E-poster | Implementation science of scaling up HIV treatment |
EPE051 | Single center experience evaluating patients for and initiating long acting cabotegravir/rilpivirine | E-poster | Implementation science of scaling up HIV treatment |
EPE052 | Implementation of the CD4 advanced disease rapid test: lessons learned from the pilot test in Uganda | E-poster | Implementation science of scaling up HIV treatment |
EPE053 | Virological outcomes and ARV switch profiles one year after dolutegravir transition among children in southern Mozambique | E-poster | Implementation science of scaling up HIV treatment |
EPE054 | HIV test and treat policy increases retention on ART in Zambian adults living with HIV. A multi-site cross sectional time series analysis | E-poster | Implementation science of scaling up HIV treatment |
EPE055 | Experiences and early lessons from adoption and introduction of the generic paediatric Dolutegravir 10mg dispersible, scored tablets (pDTG) in Malawi | E-poster | Implementation science of scaling up HIV treatment |
EPE056 | High mean weight gain among patients on Dolutegravir in Malawi | E-poster | Implementation science of scaling up HIV treatment |
EPE057 | An increase in pediatric ART retention after the HIV test and treat policy implementation. A multi-site longitudinal analysis | E-poster | Implementation science of scaling up HIV treatment |